Leidos Wins $2.7B Army Hypersonic Production Contract, Accelerates TPS and CHGB Transition
The $2.7B figure covers transition, not full-rate production — meaning this is a bridge contract. If Leidos executes cleanly, they'll compete for the LRIP and full-rate contracts that follow, potentially worth $8-12B over the next decade. If manufacturing stumbles, RTX (Raytheon) and Northrop Grumman have both signaled interest in hypersonic production.
The real constraint is supply chain — solid rocket motors, guidance systems, and heat-resistant materials are bottlenecks across the industrial base. Leidos will need to lock in suppliers now or watch timelines slip in 2027.
Leidos now owns the critical path for two separate hypersonic production lines simultaneously — TPS and CHGB — which means the Army's hypersonic deployment timeline hinges on a single prime's manufacturing cadence and supply chain.
If Leidos hits production targets, both systems accelerate into fielding by 2028-2029. If they slip, the Army loses two parallel options and faces a single-point-of-failure risk on a capability the Pentagon has positioned as central to peer competition with China and Russia. Watch the Q3 2026 production readiness review and the FY27 LRIP quantities — if the Army reduces unit commitments, it signals confidence issues.
What are the actual production rates per year for TPS and CHGB under this contract, and does Leidos have dedicated manufacturing lines for each, or are they sharing capacity?
Fault Lines
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.